九强生物:11月14日召开董事会会议

Group 1 - The core point of the article is that Jiukang Biological (SZ 300406) held its 22nd meeting of the 5th Board of Directors on November 14, 2025, to discuss the election of committee members [1] - Jiukang Biological's revenue composition for the year 2024 is 100% from the healthcare sector [1] - As of the report, Jiukang Biological has a market capitalization of 8.1 billion yuan [1]

BSBE-九强生物:11月14日召开董事会会议 - Reportify